Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 61 - 70 of 100+ results
Oncology
18 years of experience
Bile Duct Cancer (Cholangiocarcinoma), Biliary Cancer, Bowel Cancer + 9more

Dr Nikos Diamantis is a Medical Oncology Consultant at St Bartholomew's Hospital specialising in colorectal, oesphageal, gastric, pancreatic, liver and bile duct cancers, and cancers of unknown primary. He is the Barts Trust Lead for Acute Oncology and Cancer of Uknowon Primay.

Dr Diamantis underwent specialist training at the Imperial College Healthcare Hammersmith, St Mary's and Harefield Hospitals. He was awarded the Greek national Oncology fellowship scholarship and went on to conduct clinical research for 2 years at the Drug Development Unit of the Royal Marsden.

Research interests include immunotherapy for GI malignancies and first in human clinical trials. Dr Diamantis is a Principal Investigator for a number of Phase 2 and 3 trials.



.

Read more
Oncology
20 years of experience
Lung Cancer, Medical Oncology, Mesothelioma

Dr Dionysis Papadatos-Pastos is a Consultant Medical Oncologist at University College London Hospitals and Clinical Lead for Acute Oncology at Princess Alexandra Hospital, with specialist interests in the treatment of Lung Cancer and Mesothelioma.

Dr Papadatos-Pastos graduated with First Class honours in both Medicine at the University of Athens and his PhD in Medical Oncology in 2012, completing his medical oncology training at Guy’s and St Thomas’, St George’s University Hospitals and The Royal Marsden and undertaking his specialist certificate in Medical Oncology at the Institute of Cancer Research at the University of London.

Dr Papadatos-Pastos has conducted formal research into prognostic and predictive biomarkers, and the combination of immunotherapy drugs with novel compounds, participating in a number of drug trials, presenting his findings at conferences worldwide and publishing in peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer. He has also received the ASCO merit award in 2010.

 

 

 

 

 

 

 

 

 


Diseases, Medical Tests and Treatments
  • Development of novel targeted therapies for the treatment of lung cancer
  • Assessment pf combinations of immunotherapy drugs with other anti-cancer compounds
  • Lung
  • Nonsmall cell lung
  • Small cell lung cancer
  • Malignant mesothelioma
Read more
Oncology
14 years of experience
Brain Cancer, Chondrosarcoma, Chordoma + 3more

Dr Michael Kosmin is a Consultant Clinical Oncologist at University College London Hospital (UCLH) and the National Hospital for Neurology and Neurosurgery. After completing his medical training at the University of Cambridge and University College London, Michael undertook his core medical training and Clinical Oncology training within the north London region. Michael has gone onto develop significant expertise in the use of radiotherapy and chemotherapy for the management of tumours of the central nervous system. He has a particular interest in advanced radiotherapy techniques including stereotactic radiotherapy and proton beam therapy.
In addition to his clinical practice, Michael is an honorary Clinical Senior Lecturer at the UCL Cancer Institute. He leads several research projects that have received competitive funding, and he collaborates closely with clinical and academic colleagues in the design and delivery of studies evaluating the use of advanced neuro-imaging to personalise and optimise radiotherapy treatment for brain tumours.
He is the Royal College of Radiologists’ College Tutor and the local postgraduate medical education lead for clinical oncology at UCLH. He speaks regularly to expert and lay audiences on the management of brain tumours.

Read more
Oncology
51 years of experience
Breast Cancer, Clinical Oncology, Myeloproliferative Neoplasms (MPN)

Professor Jeffrey Tobias is a Consultant Clinical Oncologist who specialises in Breast cancer and haematological malignancies.


Diseases, Medical Tests and Treatments
  • Breast cancer
  • Myeloma
Read more
Oncology
14 years of experience
Clinical Oncology, Head and Neck Cancers

Dr Miguel Reis Ferreira is a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust and Adjunct Senior Clinical Lecturer at King’s College London. He specialises in the management of head and neck cancers including: mouth cancer, laryngeal cancer, throat cancers, salivary gland cancer, nose and sinus cancer and nasopharyngeal cancer. Dr Reis Ferreira treats these conditions using radiotherapy, chemotherapy and immunotherapy.

He completed his medical degree and specialist training in Lisbon, Portugal. He obtained a highly prestigious Gulbenkian PhD award and subsequently moved to the UK to develop research at the Institute of Cancer Research (IRC) and the Royal Marsden NHS Trust. During his PhD he discovered that bacteria predict patients at higher risk of developing radiation-induced side-effects.

Dr Reis Ferreira currently leads a programme of clinical and translational research at King’s investigating whether bacteria and immune cells can help to personalise and improve treatment of patients with head and neck cancer.

He is a member of the Royal College of Radiologists, Collegiate Member of the Royal College of Physicians and European Society of Radiotherapy and Oncology. 

Read more
Dr. Yin Wu

Dr. Yin Wu

1.74 miles

Dr. Yin Wu

1.74 miles
Oncology
11 years of experience
Advanced Melanoma, Medical Oncology, Skin Cancer

Dr. Yin Wu is an Honorary Consultant Medical Oncologist at Guy's and St. Thomas' NHS Foundation Trust and a clinician scientist at King's College London.  He specialises in immunotherapy and treatment of melanoma in his NHS practice and he also practices privately.

Dr. Wu read preclinical medicine at the University of Cambridge where he continues to teach undergraduate medical and veterinary students as a Bye-Fellow in pathology. He went on to complete his clinical studies at University College London on the MBPhD programme.  His PhD focussed on the role of unconventional T cells in human health and disease and he has pursued this research throughout his post-doctoral training.  After completing his medical studies, he trained in general internal medicine and medical oncology at Guy's and St. Thomas' Hospitals and University College Hospital as an NIHR Academic Clinical Lecturer.  He was appointed as an Honorary Consultant at Guy's Hospital in 2021.

Dr. Wu currently chairs the Guy's Hospital Skin Cancer Clinical Trials committee. In addition to clinical work, he is active in basic laboratory research where his work is focussed on defining the role of tissue-resident T cells in fighting cancer with a view to improving cancer immunotherapy for patients.

Read more
Dr Mary Lei

Dr Mary Lei

1.74 miles

Dr Mary Lei

1.74 miles
Oncology
21 years of experience
Clinical Oncology, Head and Neck Cancers, Laryngeal Cancer + 1more

Dr Mary Lei undertook her undergraduate medical training at King's College London School of Medicine and Dentistry and completed specialist training in clinical oncology at Imperial College Healthcare and Guy's and St Thomas' NHS Foundation Trusts.

Dr Lei spent two years as a research fellow in the Royal Surrey County Hospital and the University of Surrey. Her research focused on image-guided intensity-modulated radiotherapy (IMRT) in head and neck cancer and culminated in the award of a Medical Doctorate (MD) postgraduate degree. She was then appointed to a one year charity funded IMRT fellowship in head and neck cancer at Guy's and St Thomas' NHS Foundation Trust.

During her training, Dr Lei was the Chair of the Oncology Trainee Forum, representing the interests of clinical oncology trainees across the UK at the Royal College of Radiologists. She continues to be active in developing clinical oncology training in addition to roles as an educational and clinical supervisor.

Dr Lei has been a consultant clinical oncologist specialising in the treatment of head and neck and thyroid tumours at Guy's and St Thomas' NHS Foundation Trust since 2011. Currently, she is the lead for the clinical oncology radiotherapy research and development (R&D) group and also leads to research and development for the network thyroid cancer team.

Her research interests include novel therapies and predictive biomarkers in head and neck cancer. She is collaborating with colleagues in King's Health Partners on her work in this area.


Diseases, Medical Tests and Treatments


  • Radiotherapy
  • Head
  • Neck
  • Thyroid
  • Neuroendocrine tumours
Read more
Dr Daniel Smith

Dr Daniel Smith

1.74 miles

Dr Daniel Smith

1.74 miles
Oncology
21 years of experience
Breast Cancer, Clinical Oncology, Lung Cancer + 2more

Dr Daniel Smith is a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust. He specialises in the treatment of thoracic and breast cancers including: Lung Cancer, Breast Cancer, Mesothelioma, Thymic tumours, Chemotherapy, Radiotherapy. He also delivers immediate post-operative radiotherapy for benign conditions including: Heterotopic Ossification (HO) and Pigmented Villonodular Synovitis (PVNS). He has a particular focus on high precision techniques including 3D and 4D conformal image-guided radiotherapy (IGRT), intensity modulation radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and stereotactic ablative radiotherapy (SABR).

Dr Smith is the Lead Clinician for Lung Cancer at Guy’s & St Thomas’, one of the largest lung cancer services in the country. He is the Clinical Governance Lead for the Oncology Directorate, has published papers in international journals on IMRT and the incorporation of nuclear medicine into practice, and is an investigator in several active clinical trials. He gained a First Class degree at the University of Cambridge and completed medical training at University College London Medical School. He became a member of the Royal College of Physicians in 2004 and a fellow of the Royal College of Radiologists in 2008 following higher clinical oncology training in North London.


Diseases, Medical Tests and Treatments
  • Immunotherapy
  • Chemotherapy
  • 3D and 4D conformal image-guided radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Volumetric modulated arc therapy (VMAT)
  • Stereotactic Radiotherapy (SABR)
  • Heterotopic Ossification (HO)
  • Pigmented Villonodular Synovitis (PVNS)
  • Lung Cancer
  • Breast cancer
  • Mesothelioma
  • Thymic tumours
Read more
Oncology
Offers video consultation
21 years of experience
Colorectal Cancer, Anal Cancer, Bile Duct Cancer (Cholangiocarcinoma) + 6more

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

https://scholar.google.co.uk/citations?user=yfq8mGcAAAAJ&hl=en&oi=ao

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at asarwar@theloc.com


Diseases, Medical Tests and Treatments

  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies
Read more
Oncology
19 years of experience
Clinical Oncology, Lung Cancer, Mesothelioma + 2more

Dr Wilson is a Consultant Clinical Oncologist specialising in the treatment of thoracic malignancies (non-small cell lung cancer, small-cell lung cancer, mesothelioma, thymoma). He also offers radiotherapy for skin cancers (basal cell carcinoma, squamous cell carcinoma).


James Wilson completed his DPhil (PhD) at the University of Oxford in 2015, having been awarded a Cancer Research UK/Engineering and Physical Sciences Research Council fellowship. He finished his training at the Royal Marsden Hospital and was awarded a prestigious National Institute for Health Research Clinical Lectureship position at The Institute of Cancer Research in 2016. He is a member of the Royal College of Physicians and fellow of the Royal College of Radiologists.


He is a core member of the oligometastatic multi-disciplinary team (MDT) and offers stereotactic radiotherapy for primary and secondary lung cancers and metastases to the spine, bone and other sites. He represents clinical oncology at the specialist spinal tumour MDT at the National Hospital for Neurology and Neurosurgery.


Dr Wilson has worked in London's leading cancer centres. He is a Consultant Clinical Oncologist at University College London Hospital. As an Associate Professor at UCL he is leading research to improve treatment outcomes for patients. Dr Wilson is a specialist committee member for NICE (National Institute for Health and Care Excellence).


Diseases, Medical Tests and Treatments

  • Thymoma
  • Thymic carcinoma
  • Non-small cell lung cancer
  • Small cell lung cancer
Read more